How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

This widely used method of calculating returns considers a portfolio's cash flows Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles ...

A TikTok video of a novel, ancient multiplication method has gone viral. While the user, jesslouisec, calls the method Japanese multiplication and some mathematicians say it’s “Vedic multiplying,” its ...

Springer Nature is a signatory of the San Francisco Declaration on Research Assessment (DORA). Because small numbers of highly cited articles can have outsized influence on certain citation measures ...

We developed an optogenetic tool based on tetanus neurotoxin — a protease that cleaves the synaptic vesicle fusion protein VAMP2 to inhibit neurotransmitter release. We show that this light-controlled ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...